M Schroter

Summary

Affiliation: University of Hamburg
Country: Germany

Publications

  1. ncbi Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 38:745-7. 2000
  2. ncbi Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients
    P Schafer
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, Hamburg, Germany
    J Med Virol 61:488-96. 2000
  3. ncbi Definition of false-positive reactions in screening for hepatitis C virus antibodies
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universit äts Krankenhaus Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 37:233-4. 1999
  4. ncbi Relevance of reactivity in commercially available hepatitis C virus antibody assays
    S Polywka
    for Medical Microbiology and Immunology, University Hospital Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 39:1665-8. 2001
  5. ncbi Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Germany
    J Viral Hepat 9:455-9. 2002
  6. ncbi Low risk of vertical transmission of hepatitis C virus by breast milk
    S Polywka
    Institute for Medical Microbiology and Immunology, University Hospital Eppendorf, 20246 Hamburg, Germany
    Clin Infect Dis 29:1327-9. 1999
  7. ncbi False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation
    P Schafer
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Germany
    J Clin Microbiol 38:3249-53. 2000
  8. ncbi Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    J Clin Virol 23:57-63. 2001
  9. ncbi Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Martinistrabetae 52, 20246 Hamburg, Germany
    J Med Virol 64:320-4. 2001
  10. ncbi Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 37:2576-80. 1999

Detail Information

Publications16

  1. ncbi Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 38:745-7. 2000
    ..Although the majority of breast milk samples from viremic mothers are positive by TTV PCR, there is no need to discourage women from breast-feeding, because most children are TTV viremic even before breast-feeding begins...
  2. ncbi Cytomegalovirus cultured from different major leukocyte subpopulations: association with clinical features in CMV immunoglobulin G-positive renal allograft recipients
    P Schafer
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, Hamburg, Germany
    J Med Virol 61:488-96. 2000
    ..Factors involved in PBMCs tropism may help to understand the pathogenetic mechanisms of CMV dissemination in this group of patients...
  3. ncbi Definition of false-positive reactions in screening for hepatitis C virus antibodies
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universit äts Krankenhaus Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 37:233-4. 1999
    ....
  4. ncbi Relevance of reactivity in commercially available hepatitis C virus antibody assays
    S Polywka
    for Medical Microbiology and Immunology, University Hospital Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 39:1665-8. 2001
    ..Overall, 85.6% of reactivities were confirmed, 13.2% were shown to be unspecifically reactive, and 1.2% were indeterminate. The rate of confirmed MEIA reactivities clearly depended on the strength of the reactivity...
  5. ncbi Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Germany
    J Viral Hepat 9:455-9. 2002
    ..The hepatitis-inducing capacity of SENV-H is unclear. However, taking our clinical and epidemiological data into account it seems unlikely that this virus is responsible for hepatitis...
  6. ncbi Low risk of vertical transmission of hepatitis C virus by breast milk
    S Polywka
    Institute for Medical Microbiology and Immunology, University Hospital Eppendorf, 20246 Hamburg, Germany
    Clin Infect Dis 29:1327-9. 1999
    ..These results indicate that HCV infection in pregnant women should not be a contra-indication for breast-feeding...
  7. ncbi False-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation
    P Schafer
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Germany
    J Clin Microbiol 38:3249-53. 2000
    ..In conclusion, delayed preparation of plasma samples bears a significant risk of false-positive CMV PCR results, probably due to leukocyte lysis. This has important implications in the clinical setting and for PCR standardization...
  8. ncbi Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany
    J Clin Virol 23:57-63. 2001
    ..Determination of hepatitis C virus (HCV) genotypes and subtypes is of rising clinical importance. In times where also an increasing need for cost effectiveness can be observed, the demand for fast and easy performable assays grows...
  9. ncbi Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Martinistrabetae 52, 20246 Hamburg, Germany
    J Med Virol 64:320-4. 2001
    ..Not using immunoblot-based confirmation would result in many additional PCR examinations. Therefore, confirmation of reactive HCV EIA results by a serological confirmatory assay must remain an essential part of the diagnostic procedure...
  10. ncbi Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 37:2576-80. 1999
    ..The assay that is described provides an easier means of identification of infection with different HCV subtypes for wider clinical and epidemiological applications...
  11. ncbi Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, 20246 Hamburg, Germany
    J Clin Microbiol 39:765-8. 2001
    ..Sera from 81 patients were tested by Light Cycler PCR, AMPLICOR HCV Monitor assay, and in-house PCR. Our data demonstrate that Light Cycler is a fast and reliable method for the detection and quantitation of HCV RNA...
  12. ncbi Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis
    M Schroter
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitats Krankenhaus Eppendorf, Hamburg, Deutschland
    Nephron 87:139-42. 2001
    ..A recently detected DNA virus (TTV) has been assumed to be responsible for posttransfusion hepatitis in humans. Until now it is unclear whether patients on maintenance hemodialysis are at increased risk of acquiring TTV...
  13. ncbi Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients
    B Zollner
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatskrankenhaus Eppendorf, Martinistr 52, 20246 Hamburg, Germany
    J Clin Virol 21:37-45. 2001
    ..Resistance-associated mutations in HIV-1 evolve even under highly active antiretroviral therapy...
  14. ncbi Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients
    P Schafer
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Hamburg, Germany
    J Med Virol 65:85-9. 2001
    ..In conclusion, the concept of the AUC should facilitate identification of patients at risk of symptomatic CMV infection...
  15. ncbi Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies
    H H Feucht
    Institute of Medical Microbiology and Immunology, Universitats Krankenhaus Eppendorf, Hamburg, Germany
    J Clin Microbiol 37:1294-7. 1999
    ..Due to the lack of risk factors for HGV/GBV-C infection of blood, other efficient transmission routes must exist. It must be assumed that HGV/GBV-C transmission may be linked to sexual activity...
  16. ncbi [Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy]
    R Laufs
    Institut fur Medizinische Mikrobiologie und Immunologie, Universitatsklinikum Hamburg Eppendorf, Germany
    Anaesthesist 51:884-9. 2002
    ..The success rate in HCV genotypes 2 and 3 is clearly higher with 70-80% than in genotypes 1 and 4 with approximately 40%. Both drugs have significant side-effects but better forms of medication are not yet available...